Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1882 1
1901 1
1938 1
1947 1
1950 2
1951 1
1952 1
1953 2
1956 2
1957 1
1958 6
1959 3
1960 2
1961 4
1962 1
1963 3
1964 4
1965 1
1966 6
1967 5
1968 6
1969 2
1970 2
1971 4
1972 6
1973 4
1974 5
1975 8
1976 2
1977 4
1978 8
1979 3
1980 5
1981 3
1982 8
1983 6
1984 5
1985 3
1986 2
1987 2
1988 4
1989 5
1990 3
1991 6
1992 3
1993 6
1994 6
1995 4
1996 12
1997 6
1998 10
1999 8
2000 12
2001 16
2002 25
2003 24
2004 22
2005 17
2006 21
2007 29
2008 23
2009 29
2010 28
2011 30
2012 35
2013 32
2014 55
2015 51
2016 49
2017 53
2018 59
2019 50
2020 43
2021 59
2022 82
2023 79
2024 56

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,077 results

Results by year

Filters applied: . Clear all
Page 1
A prognostic neural epigenetic signature in high-grade glioma.
Drexler R, Khatri R, Sauvigny T, Mohme M, Maire CL, Ryba A, Zghaibeh Y, Dührsen L, Salviano-Silva A, Lamszus K, Westphal M, Gempt J, Wefers AK, Neumann JE, Bode H, Hausmann F, Huber TB, Bonn S, Jütten K, Delev D, Weber KJ, Harter PN, Onken J, Vajkoczy P, Capper D, Wiestler B, Weller M, Snijder B, Buck A, Weiss T, Göller PC, Sahm F, Menstel JA, Zimmer DN, Keough MB, Ni L, Monje M, Silverbush D, Hovestadt V, Suvà ML, Krishna S, Hervey-Jumper SL, Schüller U, Heiland DH, Hänzelmann S, Ricklefs FL. Drexler R, et al. Among authors: buck a. Nat Med. 2024 Jun;30(6):1622-1635. doi: 10.1038/s41591-024-02969-w. Epub 2024 May 17. Nat Med. 2024. PMID: 38760585 Free PMC article.
Theranostics in Hematooncology.
Buck AK, Serfling SE, Kraus S, Samnick S, Dreher N, Higuchi T, Rasche L, Einsele H, Werner RA. Buck AK, et al. J Nucl Med. 2023 Jul;64(7):1009-1016. doi: 10.2967/jnumed.122.265199. Epub 2023 Jun 8. J Nucl Med. 2023. PMID: 37290799 Free PMC article.
Immune-restoring CAR-T cells display antitumor activity and reverse immunosuppressive TME in a humanized ccRCC mouse model.
Wang Y, Cho JW, Kastrunes G, Buck A, Razimbaud C, Culhane AC, Sun J, Braun DA, Choueiri TK, Wu CJ, Jones K, Nguyen QD, Zhu Z, Wei K, Zhu Q, Signoretti S, Freeman GJ, Hemberg M, Marasco WA. Wang Y, et al. Among authors: buck a. iScience. 2024 Jan 15;27(2):108879. doi: 10.1016/j.isci.2024.108879. eCollection 2024 Feb 16. iScience. 2024. PMID: 38327771 Free PMC article.
Cranioencephalic functional lymphoid units in glioblastoma.
Dobersalske C, Rauschenbach L, Hua Y, Berliner C, Steinbach A, Grüneboom A, Kokkaliaris KD, Heiland DH, Berger P, Langer S, Tan CL, Stenzel M, Landolsi S, Weber F, Darkwah Oppong M, Werner RA, Gull H, Schröder T, Linsenmann T, Buck AK, Gunzer M, Stuschke M, Keyvani K, Forsting M, Glas M, Kipnis J, Steindler DA, Reinhardt HC, Green EW, Platten M, Tasdogan A, Herrmann K, Rambow F, Cima I, Sure U, Scheffler B. Dobersalske C, et al. Among authors: buck ak. Nat Med. 2024 Oct;30(10):2947-2956. doi: 10.1038/s41591-024-03152-x. Epub 2024 Jul 31. Nat Med. 2024. PMID: 39085419 Free PMC article.
Radiopharmaceuticals for Treatment of Adrenocortical Carcinoma.
Michalski K, Schlötelburg W, Hartrampf PE, Kosmala A, Buck AK, Hahner S, Schirbel A. Michalski K, et al. Among authors: buck ak. Pharmaceuticals (Basel). 2023 Dec 23;17(1):25. doi: 10.3390/ph17010025. Pharmaceuticals (Basel). 2023. PMID: 38256859 Free PMC article. Review.
CXCR4-directed PET/CT with [68 Ga]Ga-pentixafor in solid tumors-a comprehensive analysis of imaging findings and comparison with histopathology.
Dreher N, Hahner S, Fuß CT, Schlötelburg W, Hartrampf PE, Serfling SE, Schirbel A, Samnick S, Higuchi T, Weich A, Lapa C, Rosenwald A, Buck AK, Kircher S, Werner RA. Dreher N, et al. Among authors: buck ak. Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1383-1394. doi: 10.1007/s00259-023-06547-z. Epub 2023 Dec 12. Eur J Nucl Med Mol Imaging. 2024. PMID: 38082196 Free PMC article.
Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma.
Leipold AM, Werner RA, Düll J, Jung P, John M, Stanojkovska E, Zhou X, Hornburger H, Ruckdeschel A, Dietrich O, Imdahl F, Krammer T, Knop S, Rosenwald A, Buck A, Sander LE, Einsele H, Kortüm KM, Saliba AE, Rasche L. Leipold AM, et al. Among authors: buck a. Leukemia. 2023 Mar;37(3):650-658. doi: 10.1038/s41375-023-01824-0. Epub 2023 Jan 31. Leukemia. 2023. PMID: 36720972 Free PMC article.
Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects.
Wang Y, Buck A, Piel B, Zerefa L, Murugan N, Coherd CD, Miklosi AG, Johal H, Bastos RN, Huang K, Ficial M, Laimon YN, Signoretti S, Zhong Z, Hoang SM, Kastrunes GM, Grimaud M, Fayed A, Yuan HC, Nguyen QD, Thai T, Ivanova EV, Paweletz CP, Wu MR, Choueiri TK, Wee JO, Freeman GJ, Barbie DA, Marasco WA. Wang Y, et al. Among authors: buck a. Mol Cancer. 2024 Mar 16;23(1):56. doi: 10.1186/s12943-024-01952-w. Mol Cancer. 2024. PMID: 38491381 Free PMC article.
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection.
Peluso MJ, Ryder D, Flavell RR, Wang Y, Levi J, LaFranchi BH, Deveau TM, Buck AM, Munter SE, Asare KA, Aslam M, Koch W, Szabo G, Hoh R, Deswal M, Rodriguez AE, Buitrago M, Tai V, Shrestha U, Lu S, Goldberg SA, Dalhuisen T, Vasquez JJ, Durstenfeld MS, Hsue PY, Kelly JD, Kumar N, Martin JN, Gambhir A, Somsouk M, Seo Y, Deeks SG, Laszik ZG, VanBrocklin HF, Henrich TJ. Peluso MJ, et al. Among authors: buck am. Sci Transl Med. 2024 Jul 3;16(754):eadk3295. doi: 10.1126/scitranslmed.adk3295. Epub 2024 Jul 3. Sci Transl Med. 2024. PMID: 38959327 Free PMC article.
Core protocol development for phase 2/3 clinical trials in the leukodystrophy vanishing white matter: a consensus statement by the VWM consortium and patient advocates.
Schoenmakers DH, Leferink PS, Vanderver A, Bonkowsky JL, Krägeloh-Mann I, Bernard G, Bertini E, Fatemi A, Fogel BL, Wolf NI, Skwirut D, Buck A, Holberg B, Saunier-Vivar EF, Rauner R, Dekker H, van Bokhoven P, Stellingwerff MD, Berkhof J, van der Knaap MS. Schoenmakers DH, et al. Among authors: buck a. BMC Neurol. 2023 Aug 17;23(1):305. doi: 10.1186/s12883-023-03354-9. BMC Neurol. 2023. PMID: 37592248 Free PMC article.
1,077 results